1. Home
  2. PFL vs CTKB Comparison

PFL vs CTKB Comparison

Compare PFL & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFL
  • CTKB
  • Stock Information
  • Founded
  • PFL 2003
  • CTKB 1990
  • Country
  • PFL United States
  • CTKB United States
  • Employees
  • PFL N/A
  • CTKB N/A
  • Industry
  • PFL Finance Companies
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PFL Finance
  • CTKB Health Care
  • Exchange
  • PFL Nasdaq
  • CTKB Nasdaq
  • Market Cap
  • PFL 374.5M
  • CTKB 430.6M
  • IPO Year
  • PFL N/A
  • CTKB 2021
  • Fundamental
  • Price
  • PFL $8.46
  • CTKB $4.01
  • Analyst Decision
  • PFL
  • CTKB Hold
  • Analyst Count
  • PFL 0
  • CTKB 4
  • Target Price
  • PFL N/A
  • CTKB $6.00
  • AVG Volume (30 Days)
  • PFL 113.7K
  • CTKB 1.2M
  • Earning Date
  • PFL 01-01-0001
  • CTKB 08-06-2025
  • Dividend Yield
  • PFL 11.53%
  • CTKB N/A
  • EPS Growth
  • PFL N/A
  • CTKB N/A
  • EPS
  • PFL N/A
  • CTKB N/A
  • Revenue
  • PFL N/A
  • CTKB $196,035,000.00
  • Revenue This Year
  • PFL N/A
  • CTKB $0.74
  • Revenue Next Year
  • PFL N/A
  • CTKB $7.85
  • P/E Ratio
  • PFL N/A
  • CTKB N/A
  • Revenue Growth
  • PFL N/A
  • CTKB N/A
  • 52 Week Low
  • PFL $6.98
  • CTKB $2.37
  • 52 Week High
  • PFL $8.62
  • CTKB $7.63
  • Technical
  • Relative Strength Index (RSI)
  • PFL 56.74
  • CTKB 59.09
  • Support Level
  • PFL $8.41
  • CTKB $3.68
  • Resistance Level
  • PFL $8.50
  • CTKB $4.19
  • Average True Range (ATR)
  • PFL 0.05
  • CTKB 0.21
  • MACD
  • PFL -0.00
  • CTKB 0.02
  • Stochastic Oscillator
  • PFL 53.57
  • CTKB 76.16

About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest

PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: